10x Genomics Inc. (TXG)
NASDAQ: TXG
· Real-Time Price · USD
13.33
0.09 (0.68%)
At close: Aug 15, 2025, 3:05 PM
10x Genomics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 644.47M | 624.66M | 610.78M | 629.74M | 631.73M | 625.45M | 618.73M | 590.98M | 568.41M | 536.2M | 516.41M | 503.71M | 497.93M | 499.17M | 490.49M | 459.18M | 405.7M | 332.76M |
Cost of Revenue | 196.59M | 194.97M | 190.97M | 214.82M | 227.67M | 228.67M | 219.13M | 178.04M | 150.31M | 130.8M | 120.39M | 111.16M | 105.3M | 82.51M | 74.09M | 65.39M | 55.28M | 60.42M |
Gross Profit | 447.88M | 429.69M | 419.81M | 414.92M | 404.06M | 396.77M | 399.6M | 412.94M | 418.1M | 405.39M | 396.02M | 392.55M | 392.63M | 416.66M | 416.4M | 393.79M | 350.42M | 272.34M |
Operating Income | -100.53M | -172.39M | -192.46M | -178.23M | -231.54M | -253.16M | -245.75M | -233.24M | -178.44M | -178.2M | -167.94M | -160.68M | -136.56M | -83.77M | -52.25M | -446M | -495.38M | -524.47M |
Interest Income | 16.95M | 17.4M | 18.45M | 19.06M | 18.39M | 17.77M | 16.91M | 15.08M | 12.81M | 9.95M | 6.65M | 3.88M | 1.91M | 725K | 206K | 218K | 197K | 264K |
Pretax Income | -79.33M | -153.4M | -177.7M | -175.92M | -233.22M | -256.91M | -248.76M | -218.58M | -166.87M | -169.93M | -161.97M | -161.55M | -138.17M | -84.29M | -53.72M | -446.34M | -494.96M | -524.75M |
Net Income | -84.6M | -157.04M | -182.63M | -182.55M | -239.78M | -264.3M | -255.1M | -223.36M | -172.29M | -174.33M | -166M | -167.23M | -142.49M | -89.08M | -58.22M | -455.35M | -504.02M | -533.14M |
Selling & General & Admin | 339.69M | 348.3M | 343.24M | 335.54M | 336.25M | 344.72M | 343.33M | 336.09M | 327.08M | 314.9M | 298.3M | 289.29M | 277.97M | 267.33M | 257.56M | 243.66M | 233.13M | 208.84M |
Research & Development | 258.61M | 260.31M | 264.7M | 253.28M | 295.01M | 303.56M | 302.02M | 310.08M | 269.46M | 268.69M | 265.67M | 263.94M | 251.23M | 233.95M | 211.75M | 189.57M | 165.13M | 139.26M |
Other Expenses | -9.2M | -9.2M | 1.66M | 1.66M | 1.66M | 151K | -1.5M | -1.5M | -1.5M | n/a | -400K | -395K | -994K | -473K | -802K | -807K | 153K | -512K |
Operating Expenses | 589.1M | 599.4M | 609.6M | 590.48M | 632.92M | 649.94M | 645.35M | 646.17M | 596.54M | 583.59M | 563.97M | 553.23M | 529.2M | 501.28M | 469.31M | 433.23M | 398.26M | 348.11M |
Interest Expense | -3K | -5K | -4K | 12K | 11K | 15K | 33K | 150K | 263K | 367K | 476K | 568K | 673K | 773K | 866K | 966K | 1.14M | 1.24M |
Selling & Marketing Expenses | 3.9M | 3.9M | 3.9M | 3.3M | 3.3M | 3.3M | 3.3M | 3.7M | 3.7M | 3.7M | 3.7M | 4.7M | 4.7M | 4.7M | 4.7M | 1.9M | 1.9M | 1.9M |
Cost & Expenses | 785.69M | 797.05M | 803.24M | 807.97M | 863.27M | 878.61M | 864.48M | 824.22M | 746.85M | 714.39M | 684.35M | 664.38M | 634.49M | 583.79M | 543.4M | 498.62M | 453.55M | 408.53M |
Income Tax Expense | 5.27M | 3.63M | 4.93M | 6.63M | 6.56M | 7.39M | 6.34M | 4.79M | 5.42M | 4.4M | 4.03M | 5.68M | 4.33M | 4.79M | 4.51M | 9M | 9.06M | 8.39M |
Shares Outstanding (Basic) | 123.76M | 122.61M | 121.6M | 120.73M | 120.07M | 119.39M | 118.57M | 117.73M | 116.71M | 115.62M | 114.76M | 114.11M | 113.57M | 112.97M | 111.9M | 110.87M | 109.87M | 108.71M |
Shares Outstanding (Diluted) | 124.51M | 122.61M | 121.6M | 120.73M | 120.07M | 119.39M | 118.57M | 117.73M | 116.71M | 115.62M | 114.76M | 114.11M | 113.57M | 112.97M | 111.9M | 110.87M | 109.87M | 108.71M |
EPS (Basic) | -0.7 | -1.3 | -1.52 | -1.53 | -2.02 | -2.23 | -2.17 | -1.91 | -1.49 | -1.53 | -1.47 | -1.48 | -1.26 | -0.79 | -0.52 | -4.23 | -4.73 | -5.04 |
EPS (Diluted) | -0.7 | -1.3 | -1.52 | -1.53 | -2.02 | -2.23 | -2.17 | -1.91 | -1.49 | -1.53 | -1.47 | -1.48 | -1.26 | -0.79 | -0.52 | -4.23 | -4.73 | -5.04 |
EBITDA | -54.18M | -127.01M | -133.99M | -131.06M | -187.69M | -210.4M | -205.11M | -178.04M | -129.52M | -135.92M | -128.49M | -129.13M | -106.47M | -53.76M | -24.59M | -419.03M | -469.87M | -502.28M |
EBIT | -79.32M | -153.4M | -177.7M | -175.91M | -233.21M | -256.9M | -248.73M | -218.43M | -166.6M | -169.56M | -161.5M | -160.99M | -137.49M | -83.52M | -52.85M | -445.38M | -493.82M | -523.51M |
Depreciation & Amortization | 40.78M | 42.03M | 43.71M | 44.85M | 45.52M | 46.5M | 43.62M | 40.38M | 37.08M | 33.65M | 33.01M | 31.86M | 31.02M | 29.76M | 28.25M | 26.35M | 23.95M | 21.23M |